These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 11309775

  • 1. The human false-negative rate of rescreening Pap tests. Measured in a two-arm prospective clinical trial.
    Renshaw AA, Lezon KM, Wilbur DC.
    Cancer; 2001 Apr 25; 93(2):106-10. PubMed ID: 11309775
    [Abstract] [Full Text] [Related]

  • 2. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
    Renshaw AA, DiNisco SA, Minter LJ, Cibas ES.
    Cancer; 1997 Oct 25; 81(5):272-6. PubMed ID: 9349513
    [Abstract] [Full Text] [Related]

  • 3. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.
    Marshall CJ, Rowe L, Bentz JS.
    Diagn Cytopathol; 1999 Mar 25; 20(3):170-4. PubMed ID: 10086244
    [Abstract] [Full Text] [Related]

  • 4. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.
    Patten SF, Lee JS, Wilbur DC, Bonfiglio TA, Colgan TJ, Richart RM, Cramer H, Moinuddin S.
    Cancer; 1997 Dec 25; 81(6):337-42. PubMed ID: 9438458
    [Abstract] [Full Text] [Related]

  • 5. False negative rate of cervical cytologic smear screening as determined by rapid rescreening.
    Renshaw AA, Bellerose B, DiNisco SA, Minter LJ, Lee KR.
    Acta Cytol; 1999 Dec 25; 43(3):344-50. PubMed ID: 10349360
    [Abstract] [Full Text] [Related]

  • 6. The AutoPap system for primary screening in cervical cytology. Comparing the results of a prospective, intended-use study with routine manual practice.
    Wilbur DC, Prey MU, Miller WM, Pawlick GF, Colgan TJ.
    Acta Cytol; 1998 Dec 25; 42(1):214-20. PubMed ID: 9479343
    [Abstract] [Full Text] [Related]

  • 7. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
    Wertlake P.
    J Reprod Med; 1999 Jan 25; 44(1):11-7. PubMed ID: 9987733
    [Abstract] [Full Text] [Related]

  • 8. A clinical trial of the AutoPap 300 QC system for quality control of cervicovaginal cytology in the clinical laboratory.
    Colgan TJ, Patten SF, Lee JS.
    Acta Cytol; 1995 Jan 25; 39(6):1191-8. PubMed ID: 7483997
    [Abstract] [Full Text] [Related]

  • 9. A practical problem with calculating the false-negative rate of Papanicolaou smear interpretation by rescreening negative cases alone.
    Renshaw AA.
    Cancer; 1999 Dec 25; 87(6):351-3. PubMed ID: 10603188
    [Abstract] [Full Text] [Related]

  • 10. Analysis of error in calculating the false-negative rate in the interpretation of cervicovaginal smears: the need to review abnormal cases.
    Renshaw AA.
    Cancer; 1997 Oct 25; 81(5):264-71. PubMed ID: 9349512
    [Abstract] [Full Text] [Related]

  • 11. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies.
    Patten SF, Lee JS, Wilbur DC, Bonfiglio TA, Colgan TJ, Richart RM, Cramer H, Moinuddin S.
    Cancer; 1997 Dec 25; 81(6):343-7. PubMed ID: 9438459
    [Abstract] [Full Text] [Related]

  • 12. A feasibility study of the AutoPap system location-guided screening.
    Lee JS, Kuan L, Oh S, Patten FW, Wilbur DC.
    Acta Cytol; 1998 Dec 25; 42(1):221-6. PubMed ID: 9479344
    [Abstract] [Full Text] [Related]

  • 13. An accurate and precise methodology for routine determination of the false-negative rate of Papanicolaou smear screening.
    Renshaw AA.
    Cancer; 2001 Apr 25; 93(2):86-92. PubMed ID: 11309772
    [Abstract] [Full Text] [Related]

  • 14. Does use of the AutoPap assisted primary screener improve cytologic diagnosis?
    Bibbo M, Hawthorne C, Zimmerman B.
    Acta Cytol; 1999 Apr 25; 43(1):23-6. PubMed ID: 9987445
    [Abstract] [Full Text] [Related]

  • 15. Detection of high grade squamous intraepithelial lesions and tumors using the AutoPap System: results of a primary screening clinical trial.
    Wilbur DC, Prey MU, Miller WM, Pawlick GF, Colgan TJ, Dax Taylor D.
    Cancer; 1999 Dec 25; 87(6):354-8. PubMed ID: 10603189
    [Abstract] [Full Text] [Related]

  • 16. One hundred percent thorough quality control rescreening of liquid-based monolayers in cervicovaginal cytopathology.
    Rowe LR, Marshall CJ, Bentz JS.
    Cancer; 2002 Dec 25; 96(6):325-9. PubMed ID: 12478679
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of automated cervical cytology rescreening using the AutoPap 300 QC System.
    Stevens MW, Milne AJ, James KA, Brancheau D, Ellison D, Kuan L.
    Diagn Cytopathol; 1997 Jun 25; 16(6):505-12. PubMed ID: 9181316
    [Abstract] [Full Text] [Related]

  • 18. The effectiveness of cytological rescreening in the reduction of false negative/positive Pap reports.
    Cernescu EC, Anton G, Ruţă S, Cernescu C.
    Roum Arch Microbiol Immunol; 2013 Jun 25; 72(2):93-104. PubMed ID: 24187808
    [Abstract] [Full Text] [Related]

  • 19. Does total manual rescreening of negative pap tests screened by the ThinPrep imaging system add any value?
    Martin EL, Michael CW, Bomeisl PE, Shyu S, Wasman JK.
    Diagn Cytopathol; 2014 Oct 25; 42(10):834-9. PubMed ID: 24554347
    [Abstract] [Full Text] [Related]

  • 20. Quality assurance in cervical smears: 100% rapid rescreening vs. 10% random rescreening.
    Amaral RG, Zeferino LC, Hardy E, Westin MC, Martinez EZ, Montemor EB.
    Acta Cytol; 2005 Oct 25; 49(3):244-8. PubMed ID: 15966284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.